Macitentan does not reduce incidence of ischemic digital ulcers in patients with systemic sclerosis
1. Macitentan, an endothelin-1 blocker, did not reduce the number of new digital ulcers in patients with systemic sclerosis. 2. ...
1. Macitentan, an endothelin-1 blocker, did not reduce the number of new digital ulcers in patients with systemic sclerosis. 2. ...
Originally published by Harvard Health. What Is It? Multiple sclerosis (MS) is a disabling neurological illness. It affects the brain and ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.